TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/22 17:30 | 9/14/22 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Kosaraju Sridhar | CA | D | M.d | 115 | 11.48 | 0 | 10 | 42 | 34 | D | |||||||||||||||
5/17/22 17:30 | 5/16/22 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Kosaraju Sridhar | CA | D | M.d | 172 | 11.48 | 0 | 15 | 232 | 21 | D | |||||||||||||||
1/4/22 18:16 | 12/30/21 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Kosaraju Sridhar | CA | D | S | -226 | 150.38 | 0 | -2 | -19 | 6 | I | |||||||||||||||
11/29/21 18:14 | 11/24/21 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Kosaraju Sridhar | CA | D | S | -225 | 150.06 | 0 | -2 | -16 | 8 | I | |||||||||||||||
10/27/21 17:19 | 10/25/21 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Kosaraju Sridhar | CA | D | S | -249 | 166.32 | 0 | -2 | -14 | 9 | I | |||||||||||||||
9/24/21 18:37 | 9/23/21 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Kosaraju Sridhar | CA | D | S | -239 | 159.04 | 0 | -2 | -12 | 11 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |